These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11315)

  • 21. Effects of fenfluramine and norfenfluramine on brain serotonin metabolism in rats.
    Fuller RW; Snoddy HD; Hemrick SK
    Proc Soc Exp Biol Med; 1978 Feb; 157(2):202-5. PubMed ID: 622385
    [No Abstract]   [Full Text] [Related]  

  • 22. Interactions of iprindole with fenfluramine metabolism in rat brain and liver.
    Hegadoren KM; Baker GB; Coutts RT; Dewhurst WG
    J Psychiatry Neurosci; 1991 Mar; 16(1):5-11. PubMed ID: 2049371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of drugs on regional brain concentrations of dopamine and dihydroxyphenylacetic acid.
    Umezu K; Moore KE
    J Pharmacol Exp Ther; 1979 Jan; 208(1):49-56. PubMed ID: 32385
    [No Abstract]   [Full Text] [Related]  

  • 24. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.
    Colado MI; Murray TK; Green AR
    Br J Pharmacol; 1993 Mar; 108(3):583-9. PubMed ID: 7682129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of electric foot shock on dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC) in different brain areas of rats.
    Fadda F; Melis MR; Argiolas A
    Boll Soc Ital Biol Sper; 1978 Sep; 54(18):1747-50. PubMed ID: 753259
    [No Abstract]   [Full Text] [Related]  

  • 26. Differential changes in DOPAC levels in the hippocampal formation, septum and striatum of the rat induced by acute and repeated neuroleptic treatment.
    Scatton B
    Eur J Pharmacol; 1981 May; 71(4):499-503. PubMed ID: 6113973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of cholinomimetic drugs in combination with amfonelic acid or spiperone on the concentration of 3,4-dihydroxyphenylacetic acid in rat brain.
    Fuller RW; Snoddy HD; Molloy BB
    Pharmacol Res Commun; 1978 Mar; 10(3):229-33. PubMed ID: 684031
    [No Abstract]   [Full Text] [Related]  

  • 28. The fenfluramine metabolite (+)-norfenfluramine is vasoactive.
    Ni W; Li MW; Thakali K; Fink GD; Watts SW
    J Pharmacol Exp Ther; 2004 May; 309(2):845-52. PubMed ID: 14752059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement of 3,4-dihydroxyphenylacetic acid and 3-methoxytyramine specific activity rat striatum.
    Di Giulio AM; Groppetti A; Algeri S; Ponzio F; Cattabeni F; Galli CL
    Anal Biochem; 1979 Jan; 92(1):82-90. PubMed ID: 426290
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of d-fenfluramine on feeding and hypothalamic 5-hydroxytryptamine and dopamine in male and female rats.
    Oluyomi AO; Datla KP; Curzon G
    Eur J Pharmacol; 1994 Apr; 255(1-3):175-83. PubMed ID: 7517881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The differential effects of morphine, oxotremorine and antipsychotic drugs on DOPAC concentrations in rat brain.
    Stanley M; Wilk S
    J Pharm Pharmacol; 1980 Aug; 32(8):567-70. PubMed ID: 6106695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response of extrapyramidal and limbic neuropeptides to fenfluramine administration: comparison with methamphetamine.
    Hanson GR; Singh N; Bush L; Gibb JW
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1197-202. PubMed ID: 1722253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biphasic effects of m-chlorophenyl-piperazine on 3,4-dihydroxyphenylacetic acid concentration in rat brain.
    Fuller RW; Snoddy HD
    Res Commun Chem Pathol Pharmacol; 1977 Jul; 17(3):551-4. PubMed ID: 897345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased plasma prolactin levels induced in rats by d-fenfluramine: relation to central serotonergic stimulation.
    Quattrone A; Di Renzo G; Schettini G; Tedeschi G; Scopacasa F
    Eur J Pharmacol; 1978 May; 49(2):163-7. PubMed ID: 149011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. During one year's neuroleptic treatment in rats striatal dopamine receptor blockade decreases but serum prolactin levels remain elevated.
    Dyer RG; Murugaiah K; Theodorou A; Clow A; Jenner P; Marsden CD
    Life Sci; 1981 Jan; 28(2):167-74. PubMed ID: 6114373
    [No Abstract]   [Full Text] [Related]  

  • 36. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
    Nomura Y; Komori T; Okuda S; Segawa T
    Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):25-30. PubMed ID: 485682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3,4-dihydroxyphenylacetic acid (DOPAC) and the rat mesolimbic dopaminergic pathway: drug effects and evidence for somatodendritic mechanisms.
    Beart PM; Gundlach AL
    Br J Pharmacol; 1980 Jun; 69(2):241-7. PubMed ID: 6108139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of para-chloroamphetamine on fenfluramine anorexia in ad libitum and stimulation-induced feeding in the rat.
    Wishart TB; Zacharko RM
    Commun Psychopharmacol; 1979; 3(5):335-9. PubMed ID: 548212
    [No Abstract]   [Full Text] [Related]  

  • 39. Simultaneous effects of p-chloroamphetamine, d-fenfluramine, and reserpine on free and stored 5-hydroxytryptamine in brain and blood.
    Martín F; Artigas F
    J Neurochem; 1992 Sep; 59(3):1138-44. PubMed ID: 1379630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of repeated fenfluramine administration on indices of monoamine function in rat brain: pharmacokinetic, dose response, regional specificity and time course data.
    Zaczek R; Battaglia G; Culp S; Appel NM; Contrera JF; De Souza EB
    J Pharmacol Exp Ther; 1990 Apr; 253(1):104-12. PubMed ID: 2329498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.